Jun 13, 2024, 01:01
Udhayvir Grewal: Three important drug-drug interactions to watch out for with capecitabine
Udhayvir Grewal, Resident Physician at Ochsner LSU Health Shreveport Academic Medical Centre, recently shared a post on X:
“Three important drug-drug interactions to watch out for with capecitabine (list not comprehensive, there could certainly be many others):
- Warfarin: exaggerated anticoagulant activity. Closely monitor INR, adjust warfarin doses accordingly. Switch to DOAC if no clear indication?
- Allopurinol: The conversion of capecitabine to 5-FU and then to FdUMP and FUTP may be reduced via inhibition of phosphorylation by Capecitabine. Consider other urate lowering drugs such as febuxostat or probenecid if possible.
- Proton pump inhibitors: Reduced dissolution of the capecitabine tablet due to increased gastric pH, leading to decreased capecitabine absorption. Consider alternative agents like H2RAs, etc if possible (this may not be feasible in all cases).”
Source: Udhayvir Grewal/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 19, 2024, 10:18
Nov 19, 2024, 10:05
Nov 19, 2024, 09:53
Nov 19, 2024, 09:44
Nov 19, 2024, 09:40
Nov 19, 2024, 09:28